SYNNOVATION THERAPEUTICS

synnovation-therapeutics-logo

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, and patient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.

#SimilarOrganizations #People #Financial #Website #More

SYNNOVATION THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Oncology

Founded:
2021-01-01

Address:
Wilmington, Delaware, United States

Country:
United States

Website Url:
http://www.synnovationtx.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
139 M USD

Technology used in webpage:
Euro Google Google Cloud


Similar Organizations

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

boundless-bio-logo

Boundless Bio

Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

century-therapeutics-logo

Century Therapeutics

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.

coriell-life-sciences-logo

Coriell Life Sciences

Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.

eikon-therapeutics-logo

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

fore-biotherapeutics-logo

Fore Biotherapeutics

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

ocean-biomedical-logo

Ocean Biomedical

Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

not_available_image

Reid Huber Board Member @ Synnovation Therapeutics
Board_member
2023-12-14

Current Employees Featured

not_available_image

Wenqing Yao
Wenqing Yao Founder @ Synnovation Therapeutics
Founder
2021-10-01

Founder


not_available_image

Wenqing Yao

Investors List

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Synnovation Therapeutics

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series A - Synnovation Therapeutics

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series A - Synnovation Therapeutics

sirona-capital_image

Sirona Capital

Sirona Capital investment in Series A - Synnovation Therapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series A - Synnovation Therapeutics

Official Site Inspections

http://www.synnovationtx.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Synnovation Therapeutics"

About | Synnovation Therapeu

Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets.See details»

Synnovation Therapeutics - Crunchbase Company …

Contact Email [email protected] Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized …See details»

Synnovation Therapeutics Management Team | Org Chart

Synnovationtx.com; 4 302573XXXX; 610704XXXX; 302498XXXX; 302545XXXX; View Similar People. Related Companies Winklevoss Capital. 12 $7m PracticePanther. 49 $16.3m Katabat. …See details»

Synnovation Therapeutics Company Profile | Management and

Www.synnovationtx.com Synnovation Therapeutics Profile and History Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve …See details»

About - Synnovation Therapeu

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.See details»

Synnovation Therapeutics - LinkedIn

Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets.See details»

Synnovation Therapeutics - Overview, News & Similar ... - ZoomInfo

Jan 25, 2024 Who is Synnovation Therapeutics. Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver …See details»

Synnovation Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Www.synnovationtx.com. Startups | Holding Company | 2021 | Delaware, United States | 10-50 | www.synnovationtx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»

Science - Synnovation Therapeu

Synnovation is committed to developing breakthrough precision medicines addressing significant unmet medical needs. Our pipeline is built around highly validated precision oncologic targets …See details»

Synnovation Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Synnovation Therapeutics, Inc. of Wilmington, DE. Get the latest business insights from Dun & Bradstreet.See details»

Synnovation Therapeutics - Products, Competitors, Financials, …

Synnovationtx.com. Overview & Products; Financials; People; Founded Year 2021. Stage Series A | Alive. Total Raised $139M. Last Raised $102M | 1 yr ago. Mosaic Score. The Mosaic …See details»

Synnovation LLC – Innovative Solutions for Real Problems

If you are looking for Synnovation Therapeutics, they are a Texas company not affiliated with us. Their website is synnovationtx.com.See details»

Recommended Stories - Yahoo Finance

WILMINGTON, Del., January 24, 2024--Synnovation Therapeutics, a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against …See details»

How Does Synnovation Therapeutics Work? – CBM

Oct 2, 2024 Website: https://www.synnovationtx.com Description: Synnovation Therapeutics is a precision oncology company that develops therapeutics aimed at helping individuals with …See details»

Org Chart Synnovation Therapeutics - The Official Board

For each of our 1,254,089 listed executives, discover their exact roles and their biographies.See details»

Science | Synnovation Therapeu

Synnovation is committed to developing breakthrough precision medicines with significant unmet medical needs. Our pipeline is built around highly validated precision oncologic targets where …See details»

Careers - Synnovation Therapeu

Synnovation Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, …See details»

How much do Synnovation Therapeutics employees make?

The average annual salary of Synnovation Therapeutics is estimated to be approximate $94,415 per year. The majority pay is between $82,985 to $106,819 per year. Visit Salary.com to find …See details»

Careers - Synnovation Therapeu

Synnovation Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, …See details»

News - Synnovation Therapeu

Jan 24, 2024 Synnovation Therapeutics Announces First Patient Dosed in Phase I Trial with SNV1521, a PARP1 Selective Inhibitor for the Treatment of Solid Tumors March 11, 2024See details»

linkstock.net © 2022. All rights reserved